tive dose theraw might be beneficial in the treatment of RDS, Surface active aerosols were produced from aqueous dispersions of mixed lipids (CLL), extracted fnnn bovine lung lavage. Particle size distributioas were measured as a funetion of humMity far two types of aerosol generators: ultrrrsoaif and jet. Lipid dispersions betore aerosolhation were prepared by sonication in an ice bath and by mechanical vortexing. Over a range of bigh huaddity greater than 60-70%, ultrasonic nebulization gave CLL lerosds with mass median aerodynamic diameters (MMAD) of 1.4 * 0.1 pm, compatible with predicted alveolar deposition fractions of 03-0.3 according to current deposition models. For humidities of 30-%%, jet nebulization gave MMAD values of 0.4-03 pm, rrhicb have lower predicted alveolar deposition. The surface pressuretime (n -t) adsomtion characteristics at 35 * 2OC of CLL dispe&ions &epari initially by vortexing or sonication were not significantly affected by ultrasonic nebulization over a 1-2 h time period. In addition, the dynamic surface tension lowering of both W s of CLL dispersion was not affected by ultrasonic nebulizrrtioo (minimum surface tension <I dyne/cm at 37OC and 100% humidity). Current interest in the treatment of the respiratory distress syndrome (RDS) with exogenous surfactant replacement has focused largely on the delivery of surfactants to infants by tracheal instiUation at b i d . However, the ability to form multicomponent surfactant aerosols with appreciable alveolar deposition fractions Pad bigh surface activity may help to expand the utility of replacement therapy to patients with aerated luogs. Abbreviations CLL, calf lung lipids DPPC, dipalmitoyl phosphatidylcholine DPPC, dipalmitoyl phosphatidylglycerol egg-PC, egg phosphatidylglycerol LPC, lyso-phosphatidylcholine MMAD, mass median aerodynamic diameter n, surface pressure n -t, surface pressure-time PC, phosphatidylcboline RDS, respiratory distress syndrome Sl, sonication in an ice bath.
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TLC, thin layer chromatography V, mechanical vortexing at room temperature Much of the present interest in exogenous surfactant replacement therapy for neonatal RDS is centered on the delivery of surfactant mixtures to the respiratory system by direct airway instillation (18, 22, 23) . In animal model experiments for such therapy, the most effective time for surfactant instillation has been found to be before, or at least very close to, the onset of breathing (22) . Current research (e.g., 10 ) also indicates that a single preventilatory dose of exogenous surfactant material can have an initial beneficial effect on lung function, which then decreases with time after instillation. The possibility thus exists that repetiand this in turn'iaises-the question of what method might be most appropriate for the delivery of surfactants to aerated lungs.
Although tracheal instillation may be a preferred method for lungs in the initial stage of ventilation, a useful technique for surfactant delivery to aerated alveoli is by surface active aerosols. Studies by several groups of investigators, Brain ef al. (2) and Watson et al. (26) , have indicated that aerosolization gives a more uniform distribution of alveolar deposition than that found with intratracheal instillation of various kinds of particles.
The use of surfactant aerosols in RDS therapy has received attention in the past. As reviewed elsewhere (18, 19) , aerosols of pure DPPC have been used in several studies on lung surfactant replacement over a decade ago. More recently, Ivey et al. (9) reported a limited clinical study with an aerosol of 9:l DPPC:DPPG. But it is complex multicomponent mixtures of naturally derived lung surfactant material that have thus far proved most useful for RDS therapy in animal model instillation studies (19, 22, 23) , and aerosols of such mixtures have received little investigation. Ikegami et al. (8) studied the effects of natural lung surfactant aerosols on excised lung pressure-volume characteristics. However, detailed descriptions of the aerosols in terms of particle size distribution, humidity dependence, or intrinsic surface activity at physiologic conditions were not reported.
The present study is concerned with the aerosolization of dispersions of mixed lipids (CLL) extracted from bovine lung lavage. The CLL vrevaration studied has been shown to be effective in improving*p&onary function and gas exchange in premature lambs (3.4, 17) . The primary focus of the work is to characterize multicomponent phospholipid aerosols in terms of surface activity and particle size distribution for nebulization by both ultrasonic and jet type aerosol generators. Ultrasonic nebulization is the technique that has generally been used in previous clinical studies with DPPC aerosols. A potential disadvantage of the ultrasonic nebulizer is that it subjects the solution to be aerosolized to sigdicant vibrational energy. Phospholipid systems in aqueous dispersion can be sensitive to such effects (19) , and it is possible that an ultrasonic nebulizer might alter the surface properties or biochemical composition of therapeutic surfactant mixtures. In addition to surface property effects, another variable studied is the humidity dependence of the particle size distribution of CLL aerosols by ultrasonic and jet nebulization. Humidity dependence is characterized because of its importance for particles entering the humid airways and its effect on alveolar deposition.
The composition of CLL was re-analyzed by TLC after 1-h and 2-h exposures to ultrasonic nebulization to rule out the possibility of significant lipid hydrolysis with this method of aerosolization. TLC analysis with the solvent system of Touchstone et al. (25) , and with the system chloroform, methanol, 7 M ammonium hydroxide 60:35:5, showed no significant cornpositional changes in CLL after ultrasonic nebulization. Furthermore, to determine speafic conversion of PC to LPC, ["C dipalmitate-labeled DPPC was mixed with CLL and nebulized for 2 h in the closed chamber of the ultrasonic nebulizer. Conversion of PC to LPC was s 2% after 2 h of wntinuous ultrasonic nebulization and reflux.
Aerosol generators. Although there are a number of different aerosol generator types, two which have been applied widely for clinical use because of their reliability and simplicity are ultrasonic and jet type nebulizers (13) .
Ultrasonic nebulizer. These experiments used a Heyer Ultrasonic Nebulizer (USE 77) with an operating frequency of 2.5-2.8 megaHertz. An insert (medication cup) was used to minimize the volume of the solution to be nebulized. This cup was partially submerged in a liquid bath in the aerosol generator. In an ultrasonic nebulizer, vibrations are generated by a piezoelectric crystal at the convex base of the bath, and are transmitted through the bath to the solution. The ultrasonic vibrations cause the formation of capillary waves at the solution surface and these give rise to aerosol droplets. The capillary wavelength (A) between crests for an ultrasonic nebulizer is given by (1 1): where: y, surface tension; p, density of the solution; and f, vibrational frequency. The capillary wavelength (A) in Equation (1) has been shown to have a strong association with the droplet size leaving the surface of the solution being nebulized (1 1). If surface tension approaches zero, Equation (1) predicts that capillary waves will not form. Although y does approach zero for lung surfactant films, this is only true under dynamic wmpression. In the absence of dynamic wmpression to monolayer collapse, y is non-zero for lung surfactant component films, and ultrasonic nebulization of CLL dispersions occurs readily as shown in "Results." For the ultrasonic nebulizer, the humidity of the aerosol leaving the generator is initially high, generally > 8 M .
Jet nebulizer. Jet experiments were done with a Dautrebande D-30 nebulizer. In a jet-type nebulizer, gas passes through a nozzle at high velocity. This causes a low pressure that entrains liquid droplets from the solution in the nebulizer reservoir. Many of these recruited (or primary) droplets are recycled back into the reservoir solution as they impact on structures within the nebulizer. For the D-30 jet nebulizer used in this study, a network of small capillary holes (D = 1-2mm) was present to cause the impaction and reflux of large aerosol droplets. Because of the complex geometry and flow patterns that affect particle size distributions from jet nebulizers, no generally applicable correlation is available for a priori prediction of aerosol size distribution (13) . For jet type nebulizers, the humidity of the aerosol initially generated is low, of order 4045%.
Particle size distributions. The wntinuous flow system used to measure aerosol particle size distribution as a function of humidity is described in detail by Marks et al. (12) . In brief, compressed filtered air was delivered to a given nebulizer to generate an aerosol stream. This aerosol was then mixed with a diluting air stream of variable humidity. The humidity of the final aerosol stream was a function of the flow rates and humidities of the two air streams. The final aerosol stream was allowed to equilibrate at a given humidity by passage through a tubing system, which allowed aerosol residence times of up to 15 sec. This is several orders of magnitude larger than the times found necessary for size equilibration of saline aerosols at a given humidity (1, 6) . After equilibration, the particle size distribution of the aerosol was measured with a seven stage cascade impactor as described by Mercer et al. (14) . In this type of apparatus, the aerosol flows through small holes past a series of stages. The air passes around the stages but inertial effects cause the particles to impact on glass plates that sit on each stage. The orif~ce size for flow between each stage of the impactor decreases continuously, and the aerosol particles impact on the stages according to their aerodynamic diameter. The critical orifice at the last stage of the impactor determines the flow rate through the system.
In the experiments here, the flow rate through the impactor was 0.92 liter/min, which was provided by a piston pump (Terracon Corp, Type R 506). The impactor was designed to measure particles with aerodynamic diameters ranging from 0.166-5.3 pn. A number of other kinds of diameter such as geometric and count median diameters may be defined for an aerosol in addition to the aerodynamic diameter (13); however, for clinical purposes, the aerodynamic diameter is probably the most useful because it relates directly to the pulmonary deposition pattern of the aerosol. For the experiments here, the aerodynamic diameter measured is the activity median aerodynamic diameter, equivalent to the MMAD.
The mass of "dry" material (NaCl and CLL) deposited on each impactor stage was measured from the activity of a [-Tc] label which was used to mark the aqueous phase. This label then remained with the dry particles on the impactor stages after water evaporation. Since the Tc activity of the solution in the aerosol generator was known, the mass of NaCl (or CLL) on a given stage could be found as: Because the CLL being nebulized was a highly multiwmponent amphipathic mixture, it was necessary to verify that it was nebulized proportionally with the aqueous phase by the aerosol en- 9 4 erator. This was studied in a double label experiment with [ C] DPPC, which is the major component of CLL (and also of lung surfactant). The ["C] DPPC was mixed with CLL in chloroform, where the lipids are totally soluble. The chloroform was then evaporated under nitrogen, and the ["C] labeled lipids dispersed in 0.15 M NaCl by Si or V. The aqueous dispersions were then labeled with P T c ] , and nebulized in the jet and ultrasonic generators. These double-label experiments reported in detail by Marks et al. (12) indicated that neither CLL nor NaCl were aerosolized preferentially, and that lipid aerosol particle size distributions could be accurately measured by an aqueous phase radiolabel [*Tc].
Adsorption a -t adsorption characteristics were measured at 35 f 2OC as described previously by Notter et al. (20) . For experiments involving the adsorpiion-of lipid dispersions after exposure to ultrasonic nebulization, the procedure was as follows.
initial dispersion of 5 mg of CLL per -ml of 0.15 M NaCl was accomplished by V at room temperature (22-23°C) or by Si. These dispersions were then placed in the Heyer Generator and the output port was capped so that the nebulization compartment was closed. Nebulization was then started; the resultant aerosol droplets coalesced and refluxed back into the bulk solution. Because of the convection currents from the vigorous agitation present in the ultrasonic nebulization process, the bulk solution in the nebulizer cup was well-mixed. After a given time of wntinuous nebulization, 1 ml aliquot5 were removed from the cup solution. In r -t adsorption experiments, each 1-ml aliquot was injected beneath the surface of a stirred subphase of 70 ml of 0. I5 M NaCl, and a was then monitored as a function of time by measurement of the force on a sandblasted platinum slide dipped in the surface (20) . Adsorption experiments of this type were done for CLL dispersions subjected to wntinuous aerosolization and reflux in the closed nebulizer cup for times of 5 min to 2 hs. For this relatively long time scale of nebulization and reflux (min to h), it is reasonable to assume that the final nebulizer cup solution approximates a collection of aerosol droplets, i.e., that the majority of the CLL dispersion has gone through the actual nebulization process one or more times.
Dynamic surface tension lowering. The effect of nebulization on the magnitude of surface tension lowering achieved by CLL dispersions under dynamic compression was measured at 37°C and 100% humidity with an oscillating bubble apparatus described in detail by Enhorning (5) . Experiments involving dynamic surface pressure were done on CLL dispersions (5 mg/ml) subjected to ultrasonic nebulization for various times as described above under adsorption studies.
RESULTS

CLL-SALINE AEROSOL PARTICLE SIZE DISTRIBUTIONS
Ultrasonic nebulization. The particle size distributions for aerosols produced by ultrasonic nebulization of lipid dispersions are given as a function of humidity in Table 1 . Results are presented in terms of the MMAD and the geometric standard deviation, q. A major feature of the data in Table 1 is that the MMAD of lipid aerosols produced by ultrasonic nebulization is very stable at about 1.4 p over a range of high humidity (i.e., relative humidity > 60-70%). This MMAD stability for lipid aerosols (27) is quite different from the behavior of pure saline aerosols, which show a continuous decrease in median particle size as humidity decreases from 100% (24). Possible biophysical mechanisms for CLL aerosol stability are discussed in detail by Marks et al. (12) . For the present paper, the existence of MMAD values of 1.3-1.5 pm for relative humidity > 60-70% is most important in terms of its ramifications for pulmonary deposition as discussed later.
Jet nebulization. Particle size distribution results for CLL nebulized by the jet-generator are given in Table 2 for the cases of initial dispersion by Si and V. The results show that jet nebulized CLL particles are essentially constant in diameter as humidity is varied over the range of 30-95%. Equilibration times of 0.08-14 sec had no effect in terms of particle size measurements. The constant MMAD behavior found for CLL jet nebulization is again different from that found by jet nebulization of pure saline For a log-normal aerosol size distribution, Dm and DM can be defined as the diameter at which 50% and 84%, respectively, of the total mass of aerosol particles can be accounted for by particles of diameter D < D m or D < Dad. The geometric standard deviation o* is defined as DdDm.
Values expressed are averages of n experiments (in parentheses) over the humidity range given. Because of mechanical factors it was not possible to duplicate a given humidity exactly in repetitive experiments. solutions, which typically show a rapid rise in particle size when humidity reaches a value called the deliquescent humidity (21) . Possible mechanistic explanations for the lack of deliquescence found for CLL aerosols from the jet nebulizer are discussed by Marks et al. (12) . Eflects of nebulization on surface activity. The question of whether ultrasonic nebulization changes the surface properties of CLL mixtures was addressed by looking at the dynamic surface tension lowering and adsorption characteristics of CLL dispersions after they had been subjected to ultrasonic nebulization for various periods of time (see "Materials and Methods").
The dynamic surface tension lowering characteristics of CLL dispersions were measured at 37°C and 1Wo humidity in an oscillating bubble apparatus described by Enhorning (5) . The results presented in Table 3 are expressed as minimum and maximum surface tensions of 20-pliter aliquots of CLL dispersions (initially dispersed by V or Si) compressed and expanded between 100% area and 50% area at a rate of 20 cycles/min in the oscillating bubble. Initial dispersion concentration was 5 mg CLL/ml. The time values in Table 3 represent the length of time the CLL dispersions were subjected to continuous ultrasonic nebulization (and reflux) in the cup of the Heyer generator when an aliquot was taken for surface tension measurement. As shown in Table 3 , ultrasonic nebulization for times as long as 1 h did not change the minimum surface tension values achieved upon dynamic compression of CLL dispersions.
The n -t adsorption behavior of vortexed CLL dispersions subjected to ultrasonic nebulization for various times is shown in Figure 1 . The results indicate that the adsorption of vortexed CLL dispersions is not significantly affected by ultrasonic nebulization for times as long as 2 h. This is true in terms of both the surface pressure magnitude achieved and its time dependence. The lack of effect of ultrasonic nebulization on the adsorption of vortexed CLL dispersions is critical because such dispersions have been shown to improve lung function in premature lambs (3, 4, 17) , as noted earlier.
The effect of ultrasonic nebulization on the adsorption characteristics of sonicated CLL dispersions was also studied. The nt behavior of CLL (Si) dispersions in Figure 2 shows that the mixture adsorption properties are not significantly affected by ultrasonic nebulization for times as long as 1 h. In all cases in Figure 2 , the n -t adsorption of CLL (Si) dispersions to surface pressure values of 45 dynes/cm is rapid, and occurs over a shorter time-scale than that found for vortexed CLL dispersions at the dilute lipid concentration used (0.07 mg/ml). The n -t behavior in Figure 2A before nebulization is the same as that found previously by Notter et al. (20) for sonicated dispersions of another CLL preparation. The results in Figures 2B and 2C show that this behavior persists aAer ultrasonic nebulization (28).
DISCUSSION
The finding that ultrasonic nebulization does not adversely affect the surface tension lowering behavior of CLL dispersions is consistent with previous work (20) , which showed that the adsorption of this kind of naturally derived lipid mixture is less sensitive to heating effects than phospholipid mixtures from non-pulmonary sources (e.g., DPPC-egg PG). The results of Figures 1 and 2 show that the adsorption of CLL dispersions is also relatively unaffected by exposure to a high ultrasonic energy input in the Heyer nebulizer. In addition, the data in Table 3 show that CLL dispersions are also not significantly affected in terms of dynamic surface tension lowering ability when subjected to ultrasonic nebulization.
For any surface active mixture of potential use in inhalation therapy for RDS, the pulmonary deposition characteristics of the aerosol form must be considered. The literature concerning aerosol deposition in the pulmonary system is complex, and a multitude of experimental studies and empirical correlations are available. Many of these correlations are discussed by Mercer (13) , including the ICRP Task Group on Lung Dynamics model (7) . According to this model, alveolar deposition fraction (including the respiratory bronchioles) peaks at about 0.3 for an aerodynamic diameter of 2 pi, and is still above 0.2 for diameters of 1 or 3 pm. Consequently, CLL aerosols produced by ultrasonic nebulization with MMAD = 1.4 f 0.1 and a, = 1.7-1.9 should yield alveolar depositions of more than 2Wo at physiologic humidity. Because of the stability of aerosol size distribution for relative humidity >70% precise control of humidity would not be required in lipid aerosol delivery sysems used in a clinical setting. Humidity must be maintained at values above about 60%, however, or the aerosol droplets will evaporate to dry particles which will not easily grow back to droplets (Table I) .
The consumption of solution with the Heyer ultrasonic nebu-lizer was found to be in the range 0.05-0.3 ml/& for air flow rates of 0. In terms of the evaluation of surface active replacement mixtures for possible use in RDS therapy, research in the past decade has dealt most thoroughly with pulmonary delivery by direct tracheal instillation (22, 23) . A wide variety of animal model studies have demonstrated improved lung function following the instillation of multicomponent surfactant mixtures at or before the fmt breath, and this is clearly the indicated therapeutic approach when feasible. However, it is also true that pre-ventilatory tracheal instillation will not be possible for all patients suffering from a primary or secondary surfactant deficiency. The relative advantages and disadvantages of multiwmponent phospholipid aerosols compared to tracheal instillation therapy for such patients have not yet received a sufficiently comprehensive evaluation in terms of animal models studied, or mixtures and aerosol generation techniques used. Previous aerosol work has concentrated largely on nebulized DPPC, and the few studies involving multiwmponent phospholipid mixtures (8, 9) have not included detailed characterization of intrinsic aerosol surface activity at physiologic conditions. The present results for ultrasonically nebulized CLL suggest that it is one candidate (of perhaps many) which might profitably be studied further in animal models of RDS.
The MMAD values of 0.4-0.5 pm found for jet produced CLL aerosols in Table 2 are not as optimal in terms of alveolar deposition as the larger values found in ultrasonic nebulization. The ICRP model (7, 13) does predict significant alveolar deposition fractions for 0.5 pm particles, but the magnitude is not as large as the fraction predicted for 1.5 pm particles. In addition, a jet-type nebulizer h& several potential dhadvantages compared to an ultrasonic nebulizer for delivery of surface active aerosols to infants. The jet nebulizer uses a relatively large amount of solution (about 0.2 ml/&) because of the large continuous air flow rate needed for jet nebulization. By contrast, an ultrasonic nebulizer can easily be used as a demand system: aerosol can be drawn off from the generator chamber only as required by any given ventilator setting.
The jet nebulizer particle size results in Table 2 are perhaps most important because of the hysteresis they show in the humidity dependence of the phospholipid aerosols. A discussed in detail by Marks et al. (12) , the size distribution data in Tables 1 and 2 can be combined in a single plot of MMAD vs relative humidity. One feature resulting from such analysis is that CLL aerosols exposed to low humidity (-50%) will evaporate from droplets to dry particles, as noted above. If these particles are subsequently exposed to high humidity, they do not readily grow back to droplets ( Table 2 ). The ability to form stable aerosols of phospholipid particles (as opposed to droplets) may prove useful in surfactant replacement applications involving mixtures such as 7.3 DPPC:PG, which has been used in "dry" powder form by Morley et 01. (15) .
In summary, these experiments have shown that it is feasible to form multiwmponent aerosols of surface active phospholipids by ultrasonic and jet nebulization. In terms of surface property effects, it was found that the process of ultrasonic nebulization did not change the dynamic surface tension lowering effectiveness of CLL dispersions at physiologic temperature and-humidity. Moreover, the character of the n -t adsorption isotherm for CLL dispersions prepared by mechanical vortexing or sonication was not signiflcantly changed by ultrasonic nebulization for times as long as two hours. The particle size distributions found for both aerosol generation techniques at high humidity (relative humidity -709b) are compatible with some alveolar deposition. However, the alveolar deposition fraction of 0.2-0.3 predicted for CLL aerosols of MMAD 1.4 f 0.1 pm produced from ultrasonic nebulization is greater than that predicted for the smaller particles of MMAD = 0.4-0.5 pm produced from jet nebulization. It would appear possible to produce surface active aerosols of multiwmponent lipid mixtures that have potential for practical applications to neonatal RDS therapy in aerated lungs. Sci., 8: 149 (1977) . 27. Because of the stability found for CLL containing aerosols above RH = 60-70 percent, the residence time in the aerosol flow system was varied from 0.5 seconds to I5 seconds to check for possible non-cquilibrium effects. Over this residence time range, no change in particle size distribution was observed. 28. Thm is a slight slowing in adsorption rate in Figure 2C (&er 60 minutes in nebulizer) compared to Figure 2A (initial) and 2B (after 10 minutes in nebulizer). However, the adsorption rate in Figure 2C is still more rapid than that of vortcxed CLL dispersions in Figure 1 for the uniform fmal dispersion concentration (5 mg CLL/71 ml subphase) used (see "Materials and Methods"). This dilute concentration was chosen because it allows a disaimination between the adsorption isotherms of CLL (Si) and CLL (V However, a percentage of instilled surfactant probably does not reach the alveolar interface.
